CClinicalTrials.gg
RecruitingNCT06885359Updated Jul 7, 2026

CoCrMo LOCK Bipolar Femoral Heads FU

An observational study in Femoral Fractures and Hip Arthropathy, sponsored by Limacorporate S.p.a. Recruiting at 1 site in Slovenia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Limacorporate S.p.a · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

Study design: monocentric, retrospective, observational and post-market clinical study.

Purpose: To demonstrate the safety and performance of CoCrMo LOCK bipolar femoral heads. The eligible study population is represented by the entire population that underwent a hip replacement with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards at the site in accordance with the indication for use of the product.

Read the detailed description

The study is aiming to demoranstrate safety and performance of LOCK Bipolar femoral heads and will do it by considering the rate of revision of any prosthesis component and dislocation, by x-ray evaluation, by patient reported outcomes and walking/residential status. Patients are followed for 2 years after hemiarthroplasty and data are collected at 6 timepoints (pre-operative, intra-operative, at discharge, 4-months follow up, 12 months follow up and 24 months follow up).

02

Conditions studied

  • Femoral Fractures
  • Hip Arthropathy

Browse trials for

Keywords

  • Femoral head
  • Partial Hip Arthroplasty
03

In context

Femoral Fractures

293 studies on the registry are indexed under Femoral Fractures; 47 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 96 observational studies indexed under Femoral Fractures.

Browse Femoral Fractures studies →

Lead sponsor

Limacorporate S.p.a is the lead sponsor of 31 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who underwent partial hip arthroplasty with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards

Inclusion criteria

  • Displaced intracapsular hip fracture (Garden III-IV).
  • Subjects underwent a Bipolar Hemiarthroplasty with a CoCrMo LOCK Bipolar femoral head as per their Indication For Use from January 1st, 2023, onwards.
  • No concurrent joint disease at the time of the surgery.
  • Absence of severe cognitive dysfunction demonstrated by 3 or more correct answers on the Pfeiffer test.
  • Ability to ambulate independently with or without walking aids before surgery.
  • Subject willingness to participate.

Exclusion criteria

Exclusion Criteria:

  • Undisplaced or minimally displaced intracapsular hip fracture (Garden I-II).
  • Any CoCrMo LOCK Bipolar femoral head contraindication for use as reported in the current Instruction For Use.
  • Pathological fracture secondary to malignant disease.
  • Subjects with rheumatoid arthritis or symptomatic osteoarthritis.
  • Previous treatment to the same hip for a fracture at the time of the surgery.
  • Subjects who were deemed unsuitable for the surgical procedures by the anesthesiologist.
  • Severe cognitive dysfunction or cognitive impairment demonstrated by 2 or less correct answers on the Pfeiffer test.
  • Unable to walk before surgery (e.g., wheelchair or bed-ridden subjects).
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • CoCrMo LOCK bipolar femoral head implanted patient

    Patients who underwent hip arthroplasty with CoCrMo LOCK bipolar femoral heads from 1at January 2023 onwards.

06

What researchers measure

Primary outcomes

  1. Evaluation of the revision rate of CoCrMo LOCK Bipolar femoral heads at 24 months after surgery.

    Time frame: At 24 months after intraoperative visit

Secondary outcomes

  1. Evaluation of the dislocation rate (including close reduction) in subjects with CoCrMo LOCK Bipolar femoral heads at 24 months after bipolar hemiarthroplasty

    Time frame: At 24 months after intraoperative visit

  2. Evaluation of the revision incidence of any hip component for any reason at 24 months after bipolar hemiarthroplasty.

    Time frame: At 24 months after intraoperative visit

  3. Evaluation of acetabular erosion (according to Baker classification) in subjects with CoCrMo LOCK Bipolar femoral heads at 12 months after Bipolar Hemiarthroplasty.

    Time frame: At 12 months after intraoperative visit

  4. Assessment of Harris Hip Score (HHS) at 24 months after Bipolar Hemiarthroplasty with CoCrMo LOCK Bipolar femoral heads.

    The Harris Hip Score goes from 0 to 100, which is the best result.

    Time frame: At 24 months after intraoperative visit

  5. Assessment of Oxford Hip Score (OHS) completed by subjects with CoCrMo LOCK Bipolar femoral heads at 24 months after Bipolar Hemiarthroplasty.

    The Oxford Hip Score goes from 0 to 48, with 48 being the best outcome

    Time frame: At 24 months after intraoperative visit

  6. Assessment of Pain Likert-scale in subjects with CoCrMo LOCK Bipolar femoral heads at 24 months after Bipolar Hemiarthroplasty.

    The pain Likert-scale is a 6-point scale: - severe and spontaneous - severe when walking - tollerable - occurs after activity - light intermittent - no pain

    Time frame: At 24 months after intraoperative visit

  7. Comparison between pre-operative and 4-month walking ability.

    Functional evaluation At the pre-operative time-point, the ability to walk is categorized in: * "able to walk without aids", * "able to walk using one walking aid", * "able to walk using two walking aids", * "able to walk using the walking frame" * "unable to walk" (wheelchair or bed-ridden subjects) At the 4-month post-operative time-point, the ability to walk is investigated is categorized in: * "maintained" (if the subject is able to walk independently as before, with aids if necessary) * "not maintained" (if the subject needs support from another person or uses a wheelchair or is bed-ridden)

    Time frame: Performed at preoperative visit and 4months follow up visit

  8. Comparison between pre-operative and 4-month residential status.

    Daily habit At pre-operative timepoint, subjects are categorized as subjects that before the fracture were used to live: * at their own home (alone or with assistance), * in a sheltered home for independent people, * in a nursing home for people who need assistance with personal care. At 4-month post-operative timepoint, the residential status is categorised in: * maintained (if the subject is living in the same dwelling as before fracture), * not maintained (if the subject moved to a sheltered accommodation or a nursing home)

    Time frame: Performed at preoperative visit and 4months follow up visit

07

Study locations

1 of 1 sites recruiting
  • Splošna bolnišnica Celje
    Celje, 3000, Slovenia
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06885359
Lead sponsor
Limacorporate S.p.a
Responsible party
Sponsor
First posted
Mar 20, 2025
Start date
Jan 28, 2026
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jul 7, 2026

Study contacts

Monica Novello
Contact
monica.novello@enovis.com
3358162087
Francesca Citossi
Contact
clinicalresearch@enovis.com
+39 0432 945511

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion